China, Aug. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Real‑world study of immunotherapy in PARPi‑pretreated platinum‑resistant recurrent epithelial ovarian cancer'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130247
Registration Time: 2026/08/18
Type: Observational study
Primary Sponsor: Obstetris & Gynecology Hospital of Fudan University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337859
Published by HT Digital Content Services with permission from Health Daily Digest....